Disclosed dividend payments and transfers of profits in accordance with the Articles of Association were broken down as follows in the fiscal year:
| XLS |
|
|
|
|
|
€ million |
2012 |
2011 |
|
Dividends to shareholders |
–96.9 |
–80.8 |
|
Dividends to shareholders of non-controlling interest |
–5.7 |
–6.0 |
|
Dividend payments |
–102.6 |
–86.8 |
|
|
|
|
|
|
|
|
|
€ million |
2012 |
2011 |
|
Profit transfer in accordance with the Articles of Association from E. Merck KG to Merck KGaA |
2.2 |
0.8 |
|
Profit transfer in accordance with the Articles of Association from Merck KGaA to E. Merck KG |
372.0 |
–938.5 |
|
Changes in reserves of Merck KGaA by E. Merck KG |
–616.9 |
655.5 |
|
Profit transfer from Merck KGaA to E. Merck KG |
–242.7 |
–282.2 |
|
Profit transfer from Merck & Cie to E. Merck KG |
–61.8 |
–44.3 |
|
Profit transfer to E. Merck KG |
–304.5 |
–326.5 |
|
|
|
|
|
Changes in financial liabilities to E. Merck KG |
33.9 |
8.9 |
|
Changes in other liabilities to E. Merck KG |
–23.3 |
68.4 |
|
Changes in liabilities to E. Merck KG |
10.6 |
77.3 |
|
Total cash transfers to and from E. Merck KG |
–293.9 |
–249.2 |
In December 2012, Merck acquired the non-controlling interest in Allergopharma GmbH & Co. KG, Reinbek, Germany, for a purchase price of € 15.0 million.
search hit 02
